PFE

Generic Drug Stocks Soar – Your Best Healthcare Plays Are TEVA and MYL

Mylan just announced a deal to buy Abbott Labs' global generics business. MYL stock is popping now, but should run for some time thanks to the big tailwind that generic drug stocks are getting right now. More 

Top 10 Dow Dividend Stocks for June

Looking for yield as we begin the second half? Look no further than these top 10 Dow dividend stocks. More 

14 New Stocks to Watch – GoPro Ready To Ride the IPO Wave

A whopping 14 companies are preparing IPOs for this week. Here's a look at the new stocks to watch. More 

OTC Cialis? Pfizer’s Viagra Will Be Just Fine

An over-the-counter version of Cialis seems like a slam dunk for Eli Lilly (LLY), but Pfizer's (PFE) Viagra isn't exactly in a heap of trouble. More 

PFE: Pfizer to Pay $325M Fine for Illegal Marketing

Drugmaker Pfizer (PFE) has agreed to pay a $325 million to insurers and other healthcare benefit providers for falsely marketing its drug Neurontin. More 

When Fraud Bites Business: Lost Fortunes, Reputations and Lives

Credit card breaches, swindlers and even baby formula form a web of business-targeted fraud that spans the globe. More 

Top 10 Dow Dividend Stocks for May

In a low-yield environment, attractive blue-chips look even more appealing. Here are the top 10 Dow Dividend stocks for May. More